Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026

Rhea-AI Summary

Talphera (Nasdaq: TLPH) will host a conference call and webcast on Wednesday, August 12, 2026 at 4:30 p.m. ET / 1:30 p.m. PT to discuss its second quarter 2026 financial results and recent business progress. North American participants can dial 1-800-836-8184 and international participants 1-646-357-8785 using conference ID 50873. A live webcast and a 90-day replay will be available via the Upcoming Events page in the Investors section of the Talphera website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN MATEO, Calif., Aug. 5, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will host a conference call and webcast on Wednesday, August 12, 2026 at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss financial results for the second quarter ended June 30, 2026 and recent business progress.

Conference Call and Webcast Information

• Date: Wednesday, August 12, 2026 at 4:30 PM ET/1:30 PM PT
• Participant Dial-in (North America): 1-800-836-8184
• Participant Dial-in (International): 1-646-357-8785
• Conference ID: 50873
• Webcast Access: Click here 

The event can also be accessed in the Upcoming Events page in the Investors section of the Talphera website at www.talphera.com.

A replay of the webcast will be available on the Talphera website for 90 days after the event.

About Talphera, Inc.

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad^® is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit. Nafamostat has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA).

This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-report-second-quarter-2026-financial-results-on-wednesday-august-12-2026-302844071.html

SOURCE Talphera, Inc.

FAQ

When will Talphera (TLPH) report its Q2 2026 financial results?

Talphera will discuss its Q2 2026 financial results on a conference call and webcast on Wednesday, August 12, 2026 at 4:30 p.m. ET / 1:30 p.m. PT. According to Talphera, the event will also cover recent business progress.

How can investors access the Talphera (TLPH) Q2 2026 earnings conference call?

Investors can join the Talphera Q2 2026 call by dialing 1-800-836-8184 in North America or 1-646-357-8785 internationally with conference ID 50873. According to Talphera, a live webcast will also be available on its website.

Where can I find the Talphera (TLPH) Q2 2026 webcast online?

The Talphera Q2 2026 webcast can be accessed via the Upcoming Events page in the Investors section of www.talphera.com. According to Talphera, investors can click the webcast link posted for the August 12, 2026 event.

Will a replay be available for the Talphera (TLPH) Q2 2026 earnings webcast?

Yes, a replay of the Talphera Q2 2026 webcast will be available on the company’s website for 90 days after the event. According to Talphera, investors can access it through the Investors section online.

What topics will Talphera (TLPH) cover on the August 12, 2026 conference call?

The August 12, 2026 Talphera call will cover second quarter 2026 financial results and recent business progress. According to Talphera, the discussion will follow the quarter ended June 30, 2026 and be available via phone and webcast.